You are here

  • Home
  • Online First
  • Meniscal ramp lesions: anatomy, biomechanics and clinical outcomes (PhD Academy Award)

Article Text

Article menu

other Versions

Download PDFPDF
PhD Academy Award
Meniscal ramp lesions: anatomy, biomechanics and clinical outcomes (PhD Academy Award)
  1. Nicholas N. DePhillipo
  1. Oslo Sports Trauma Research Center, Norwegian School of Sports Sciences, Oslo, Norway
  1. Correspondence to Dr Nicholas N. DePhillipo, Orthopedics, Norwegian School of Sports Sciences, Oslo, Norway; Nickd.atc{at}gmail.com

https://doi.org/10.1136/bjsports-2020-102367

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    What did I do?

    The overall aim of my thesis was to systematically evaluate medial meniscal ‘ramp’ lesions and how they affect anterior cruciate ligament reconstruction (ACLR).

    Why did I do it?

    There has been a recent surge in publications in the past decade regarding meniscal ramp lesions. Ramp lesions by definition are associated with ACL tears and have a high incidence (40%) in various ACL tear populations.1 A ramp lesion involves tearing of the posteromedial meniscus at the meniscocapsular junction and is of specific interest due to its reported ‘blind spot’ when viewing arthroscopically. Its name is derived from the arthroscopic appearance of a downwards slope or ramp and authors have associated an arbitrarily tear length of 2.5 cm to describe an unstable ramp lesion.2 Because of this slope or ramp area, the posteromedial capsule of the knee creates a fold which allows for a potential hidden space, thus resulting in misdiagnosis and failure …

    View Full Text

    Footnotes

    • Contributors NND is the only author of this manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; externally peer reviewed.